Filter
1587
Text search:
drug
market
Featured
Recommendations
132
New Publications
465
Language
Document type
No document type
874
Studies & Reports
298
Guidelines
197
Strategic & Response Plan
87
Manuals
76
Fact sheets
24
Training Material
16
Situation Updates
7
Resource Platforms
5
Brochures
1
App
1
Infographics
1
Countries / Regions
India
81
Global
64
Kenya
61
Ethiopia
51
Uganda
48
Western and Central Europe
40
Ghana
37
Nigeria
36
Myanmar / Burma
33
Liberia
30
Bangladesh
30
Sierra Leone
29
Zambia
26
Malawi
26
South Africa
25
Africa
25
Nepal
21
Tanzania
21
Philippines
20
Rwanda
18
Ukraine
17
Latin America and the Carribbean
17
Congo, Democratic Republic of
16
Zimbabwe
15
Cambodia
14
Asia
13
Namibia
12
South–East Asia Region
12
Eastern Europe
12
Indonesia
10
Venezuela
10
Senegal
9
Syria
9
Guinea
8
Brazil
8
Botswana
8
Lesotho
8
Mozambique
7
Burkina Faso
6
Cameroon
6
Thailand
6
China
6
Albania
6
Russia
6
Haiti
5
Eswatini/ Swaziland
5
Eastern Europe and Central Asia
5
Vietnam
5
South Sudan
4
Sudan
4
Colombia
4
Sri Lanka
4
East and Southern Africa
4
West and Central Africa
4
USA
3
Germany
3
Benin
3
Peru
3
North Macedonia
3
Mexico
3
Middle East and North Africa
3
Laos
3
Timor Leste/ East Timor
3
Moldova
3
Georgia
3
Somalia
2
Pakistan
2
Jordan
2
Lebanon
2
Central African Republic
2
Argentina
2
Hungary
2
Libya
2
Western Pacific Region
2
Poland
2
Tajikistan
2
Iran
2
Morocco
1
Iraq
1
Afghanistan
1
Papua New Guinea
1
Switzerland
1
Serbia
1
Bolivia
1
Madagascar
1
Chile
1
Fiji
1
Bhutan
1
Palestine
1
North Korea
1
Italy
1
Canada
1
Qatar
1
Bulgaria
1
Estonia
1
Kyrgyzstan
1
Kazakhstan
1
North America
1
Turkmenistan
1
Jamaica
1
Denmark
1
Maldives
1
Norway
1
Portugal
1
Authors & Publishers
Publication Years
Category
Countries
653
Clinical Guidelines
101
Public Health
71
Key Resources
54
Pharmacy & Technologies
41
Women & Child Health
40
Capacity Building
13
Toolboxes
HIV
155
Mental Health
135
AMR
131
TB
104
Pharmacy
103
COVID-19
70
NTDs
41
Malaria
30
Planetary Health
28
Health Financing Toolbox
26
Conflict
25
Ebola & Marburg
23
Global Health Education
22
NCDs
22
Disability
18
Refugee
18
Caregiver
16
Rapid Response
13
Cholera
12
2.0 Rapid Response
7
Natural Hazards
6
Social Ethics
4
Polio
3
Specific Hazards
3
Through public-private partnerships, the government of Rwanda can make more efficient use of public resources by targeting and meeting the needs of specific populations and thus help ensure family planning services and products will be available to all Rwandans in the long term. This report aims to
...
Thousands of HIV-positive Venezuelans have been forced to leave the country, after facing discrimination and zero treatment options, according to UNAIDS.
Patients once received free ARV treatment under Venezuela’s National AIDS Program. In 2017, the country essentially ran out of ARVs—about 9 p
...
Historically, the discovery of the sulfa drugs in the 1930s and the subsequent development of penicillin during World War II ushered in a new era in the treatment of infectious diseases. Infections that were common causes of death and disease in the pre-
...
In 2007, WHO warned that infectious diseases are emerging and re-emerging at a rate that has not been seen before. The potential for infectious diseases to spread rapidly results in high morbidity and mortality, causing a potential global public health treat of major concern.
Several factors are
...
This publication seeks to describe the best treatments and practices based on the scientific evidence available at the time of writing as evaluated by the authors and may change as a result of new research. Readers need to apply this knowledge to patients in accordance with the guidelines and laws o
...
PLOS Glob Public Health 4(12): e0004035. https://doi. org/10.1371/journal.pgph.0004035.
A new formulation of praziquantel, arpraziquantel (arPZQ), has been developed for preschool-
aged children (PSAC) to fill the treatment gap for this age group in schistosomiasis control and
elimination program
...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f
...
Globally each year, millions of people suffer illness or lose their lives because the vaccines, medicines and diagnostic tests that they need are either unavailable or unaffordable – and this lack of access to medicine is acute in low- and middle-in-
come countries (LMICs). While the COVID-19 pan
...
The manufacturing process is one of the key steps where quality control is required to ensure quality of medicinal products, including herbal medicines. Good manufacturing practices (GMP) is one of the most important tools for this measure.
Rappart sur les populations clés.
Third edition
The WHO Model List of Essential Medicines and Model List of Essential Medicines for Children are updated and published every two years, intended as a guide for countries or regional authorities to adopt or adapt in accordance with local priorities and treatment guidelines for the development and upd
...
